anagrelide &#160; ingelesa (Q408163)

anagrelide (ingelesa)

3 urria 2016

formula kimikoa

C₁₀H₇Cl₂N₃O

Erreferentzia bat

anagrelide (ingelesa)

20 azaroa 2016

SMILES

C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31

Erreferentzia bat

anagrelide (ingelesa)

20 azaroa 2016

active ingredient in ^ingelesa

Agrylin ^ingelesa

Erreferentzia bat

RxNorm ^ingelesa

RxNorm ID ^ingelesa

215060

14 otsaila 2018

World Health Organisation international non-proprietary name ^ingelesa

anagrelide (ingelesa)

Erreferentzia bat

ChEBI ^ingelesa

anagrelide (ingelesa)

3 urria 2016

medical condition treated ^ingelesa

Tronbopenia

Erreferentzia bat

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

13 abendua 2016

Erreferentzia bat

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

13 abendua 2016

myeloproliferative disorders ^ingelesa

Erreferentzia bat

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

13 abendua 2016

tronbozitosi esentzial

Erreferentzia bat

Droga eta Elikagaien Administrazioa

Drug Indications Extracted from FAERS ^ingelesa

2 urria 2018

14 martxoa 1997

Erreferentzia bat

Inxight: Drugs Database ^ingelesa

https://drugs.ncats.io/drug/K9X45X0051

2 azaroa 2018

URL erreferentzia

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb960074-99c1-4a73-941f-f0644a7ec219

significant drug interaction ^ingelesa

halofantrine ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

amiodarone ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

arsenic trioxide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

astemizole ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

Azitromizina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

bepridil ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

klorokina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

klorpromazina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

cisapride ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

(RS)-citalopram ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

Klaritromizina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

kokaina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

disopyramide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

dofetilide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

domperidone ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

dronedarone ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

droperidol ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

Eritromizina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

escitalopram ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

flecainide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

haloperidol

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

ibutilide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

mesoridazine ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

Metadona

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

moxifloxazino

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

Ondansetron

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

pentamidine ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

pimozide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

probucol ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

procainamide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

Kinidina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

sevoflurane ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

sotalol ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

sparfloxacin ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

(RS)-sulpiride ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

terfenadine ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

tioridazina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

amiodarone ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Metadona

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

arsenic trioxide ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

disopyramide ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

toremifene ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

sotalol ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Eritromizina

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

dronedarone ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

eribulin ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

vandetanib ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

crizotinib ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

droperidol ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

pimozide ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

haloperidol

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

klorpromazina

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

zuklopentixol

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Hidroxizina

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-sulpiride ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

moxifloxazino

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-citalopram ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

iloprost ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Azido azetilsaliziliko

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Klopidogrel

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

eptifibatide ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

tirofiban ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

abciximab ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

prasugrel ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

ticagrelor ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-citalopram ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

pentamidine ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

domperidone ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

fisikoki honekin elkarrekintza du

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

amiodarone ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-sulpiride ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Phosphodiesterase 3A ^ingelesa

subjektuak duen rola

Entzimen inhibitzaile

Erreferentzia bat

IUPHAR/BPS Guide to PHARMACOLOGY ^ingelesa

Guide to Pharmacology Ligand ID ^ingelesa

7114

17 abuztua 2016

pregnancy category ^ingelesa

Australian pregnancy category B3 ^ingelesa

Erreferentzia bat

iturria

Ingelesezko Wikipedia

US pregnancy category C ^ingelesa

Erreferentzia bat

iturria

Ingelesezko Wikipedia

LiverTox likelihood score ^ingelesa

LiverTox toxicity likelihood category E* ^ingelesa

Erreferentzia bat

LiverTox ^ingelesa

https://www.ncbi.nlm.nih.gov/books/n/livertox/Anagrelide

8 apirila 2021

URL erreferentzia

azken eguneraketa

5 uztaila 2017

subjektuak duen rola

phosphodiesterase inhibitors ^ingelesa

Erreferentzia bat

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

5 martxoa 2018

fibrinolytic agents ^ingelesa

Erreferentzia bat

Medical Subject Headings

MeSH identifikadorea

C021139

15 martxoa 2018

platelet aggregation inhibitors ^ingelesa

Erreferentzia bat

Medical Subject Headings

MeSH identifikadorea

C021139

InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)

15 martxoa 2018

Commons-eko kategoria

Anagrelide

0 erreferentzia

Identifikatzaileak

InChI

Erreferentzia bat

anagrelide (ingelesa)

20 azaroa 2016

2 erreferentzia

anagrelide (ingelesa)

20 azaroa 2016

ChEBI release 2020-09-01 ^ingelesa

CAS zenbakia

68475-42-3

2 erreferentzia

anagrelide (ingelesa)

20 azaroa 2016

CAS Common Chemistry ^ingelesa

https://commonchemistry.cas.org/detail?cas_rn=68475-42-3

8 apirila 2021

URL erreferentzia

ChemSpider-ren identifikatzailea

2097

Erreferentzia bat

ChemSpider-ren identifikatzailea

ChemSpider ^ingelesa

2097

Anagrelide (ingelesa)

20 azaroa 2016

Erreferentzia bat

anagrelide (ingelesa)

20 azaroa 2016

135409400

Erreferentzia bat

InChIKey ^ingelesa

Reaxys registry number ^ingelesa

619582

Erreferentzia bat

ChEBI ^ingelesa

anagrelide (ingelesa)

3 urria 2016

mapping relation type ^ingelesa

exact match ^ingelesa

2 erreferentzia

ChEMBL-en identifikatzailea

ChEMBL ^ingelesa

CHEMBL760

ANAGRELIDE (ingelesa)

20 azaroa 2016

InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)

International Chemical Identifier ^ingelesa

InChI

ChEMBL-en identifikatzailea

CHEMBL760

Erreferentzia bat

ChEMBL-en identifikatzailea

ChEMBL ^ingelesa

CHEMBL760

ANAGRELIDE (ingelesa)

20 azaroa 2016

SureChEMBL ID ^ingelesa

SCHEMBL9411

2 erreferentzia

based on heuristic ^ingelesa

inferred from InChIKey ^ingelesa

InChIKey ^ingelesa

SCHEMBL318594

2 erreferentzia

based on heuristic ^ingelesa

inferred from InChIKey ^ingelesa

InChIKey ^ingelesa

HSDB ID ^ingelesa

7325

Erreferentzia bat

Hazardous Substances Data Bank ^ingelesa

HSDB ID ^ingelesa

7325

argitaratze-data

28 urria 2019

ANAGRELIDE (ingelesa)

10 maiatza 2021

DSSTox substance ID ^ingelesa

DTXSID4048305

0 erreferentzia

DSSTOX compound identifier ^ingelesa

DTXCID6028280

0 erreferentzia

LiverTox ID ^ingelesa

Anagrelide

0 erreferentzia

ECHA Substance Infocard ID ^ingelesa

0 erreferentzia

Erreferentzia bat

DrugBank ^ingelesa

DrugBank ID ^ingelesa

00261

Anagrelide (ingelesa)

argitaratze-data

17 azaroa 2015

Guide to Pharmacology Ligand ID ^ingelesa

7114

Erreferentzia bat

IUPHAR/BPS Guide to PHARMACOLOGY ^ingelesa

Guide to Pharmacology Ligand ID ^ingelesa

7114

anagrelide (ingelesa)

20 azaroa 2016

Erreferentzia bat

Medical Subject Headings

MeSH identifikadorea

C021139

14 martxoa 2018

RxNorm ID ^ingelesa

596724

Erreferentzia bat

anagrelide (ingelesa)

20 azaroa 2016

DrugBank ID ^ingelesa

DB00261

Erreferentzia bat

InChIKey ^ingelesa

Human Metabolome Database ID ^ingelesa

HMDB0014406

2 erreferentzia

based on heuristic ^ingelesa

inferred from InChIKey ^ingelesa

InChIKey ^ingelesa

2 erreferentzia

anagrelide (ingelesa)

20 azaroa 2016

InChIKey ^ingelesa

MedlinePlus drug identifier ^ingelesa

a601020

0 erreferentzia

NDF-RT ID ^ingelesa

Erreferentzia bat

anagrelide (ingelesa)

KEGG-ren identifikatzailea

20 azaroa 2016

Probes And Drugs ID ^ingelesa

PD010137

0 erreferentzia

D07455

Erreferentzia bat

ChEBI ^ingelesa

anagrelide (ingelesa)

Freebase-ren identifikatzailea

3 urria 2016

/m/08jmnq

Erreferentzia bat

Microsoft Academic identifikatzailea

Freebase Data Dumps ^ingelesa

argitaratze-data

28 urria 2013

0 erreferentzia

Erreferentzia bat

26 urtarrila 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

Römpp online ID ^ingelesa

Erreferentzia bat

UMLS CUI ^ingelesa

Erreferentzia bat

anagrelide (ingelesa)

20 azaroa 2016

C0106591

Erreferentzia bat

based on heuristic ^ingelesa

inferred by common MeSH mappings on source and on Wikidata ^ingelesa

UMLS 2023 ^ingelesa